← Browse by Condition
Medical Condition

lgg

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for lgg sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Pfizer 1 trial
Fore Biotherapeutics 1 trial
NCT05538130 Phase 1
Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Enrollment
124 pts
Location
United States, Austr...
Sponsor
Pfizer
View Trial →
NCT05503797 Phase 2
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Enrollment
254 pts
Location
United States, Austr...
Sponsor
Fore Biotherapeutics
View Trial →